Southport Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
BL
Southport Capital Management's XBI Position: Q4 2018 in Review
Southport Capital Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2018, closing a stake of 222 shares — an estimated $21K sold.
Southport Capital Management first reported a position in XBI in Q3 2018 and held it in 1 quarter. The position peaked at $21K in Q3 2018. 427 funds tracked by Wall St. Rank hold XBI as of Q4 2018.
- Southport Capital Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2018 after selling out during the quarter.
- Southport Capital Management sold 222 State Street SPDR S&P Biotech ETF shares in Q4 2018, an estimated $21K.
- Southport Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2018 and held it in 1 quarter.
- Southport Capital Management's State Street SPDR S&P Biotech ETF position peaked at $21K in Q3 2018.
- 427 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2018.
Based on Southport Capital Management's 13F filing for Q4 2018, filed 18 Jan 2019.